ストックスクリーナーアプリを入手
2.21
3.07%
-0.07
アフターアワーズ：
2.11
-0.10
-4.52%
Telomir Pharmaceuticals Inc (TELO) 最新ニュース
Pre-market Movers: PMN, GCTK, TELO, SRPT... - RTTNews
Is Telomir Pharmaceuticals Inc. a good long term investmentSuperior investment outcomes - Autocar Professional
What analysts say about Telomir Pharmaceuticals Inc. stockTremendous growth opportunities - Autocar Professional
Telomir Pharmaceuticals Inc. Stock Analysis and ForecastExceptional gains - jammulinksnews.com
What drives Telomir Pharmaceuticals Inc. stock priceDynamic investment opportunities - Autocar Professional
Why Is Telomir Pharmaceuticals Stock (TELO) Up 150% Today? - MSN
Healthcare Stocks Move in Pre-Market Session: Telomir Pharmaceuticals, Mesoblast, and More - AInvest
Telomir Demonstrates Telomir-1 Reverses Epigenetic Gene Silencing of STAT1, Restoring Tumor Suppressor in Human Prostate Cancer Cells, Outperforming Chemotherapy and Rapamycin - Lohud
Telomir Pharmaceuticals Stock Price, Quotes and Forecasts - Benzinga
Telomir skyrockets on preclinical data backing epigenetic potential of lead asset - FirstWord Pharma
Dow Falls Over 200 Points; 3M Earnings Top Views - Benzinga
Telomir Pharma Skyrockets Nearly 139% After-Hours As Cancer Drug Shows Breakthrough Results, Beats Chemo In Human Cell Tests - NewsBreak: Local News & Alerts
Telomir Pharmaceuticals Skyrockets 150% on Breakthrough Preclinical Cancer Results - MSN
Telomir Pharmaceuticals: A Disruptive Force in Prostate Cancer Therapy with Epigenetic Innovation - AInvest
Telomir Pharmaceuticals stock soars after promising cancer treatment data - Investing.com
Telomir Pharma Jumps In After-Hours Trading After Drug Reverses Damage In Progeria Cells; Retail Eyes Bigger Gains - Stocktwits
Telomir Pharmaceuticals stock soars after promising cancer treatment data By Investing.com - Investing.com UK
Cancer Breakthrough Sends Telomir Pharma Stock Exploding 157% - Wall Street Pit
Telomir-1 shows stronger epigenetic effects than standard drugs in cancer study - Investing.com Australia
Telomir-1 shows stronger epigenetic effects than standard drugs in cancer study By Investing.com - Investing.com South Africa
Revolutionary Cancer Treatment Shows 50% Tumor Reduction, Beats Standard Chemotherapy in Clinical Tests - Stock Titan
TELO’s Stock Tango: The Dance of Gains and Losses in 2025 - investchronicle.com
Published on: 2025-07-18 16:06:06 - jammulinksnews.com
Telomir Pharmaceuticals Stock Soars 123.97% on Promising Cancer Drug Data - AInvest
Telomir Pharma Jumps In After-Hours Trading After Drug Reverses Damage In Progeria Cells Retail Eyes Bigger Gains - Menafn.com
Telomir says data show Telomir-1 reversed epigenetic silencing - TipRanks
What makes Telomir Pharmaceuticals Inc. stock price move sharplySmart Money Trade Setups - Newser
How Telomir Pharmaceuticals Inc. stock performs during market volatilityProfit Focused Trade Alerts - Newser
Why Telomir Pharmaceuticals Inc. stock attracts strong analyst attentionStable Stocks With High Yield - Newser
Telomir Pharmaceuticals (NASDAQ:TELO) Trading Down 18.3% – Should You Sell? - Defense World
Telomir Pharmaceuticals, Inc.(NasdaqCM: TELO) dropped from Russell 3000 Value Index - MarketScreener
TELO Rises on Promising Telomir-1 Preclinical Results - MSN
Telomir Pharmaceuticals Prevents Cellular Aging in Patient-Derived Cells from Children with Progeriaan Ultra-Rare Genetic Disorder that Causes Rapid Aging - Knoxville News Sentinel
# Telomir-1 shows anti-aging effects in progeria cell study By Investing.com - Investing.com South Africa
Telomir Pharmaceuticals reports positive results for progeria treatment By Investing.com - Investing.com South Africa
0.87%
0.17%
大文字化:
|
ボリューム (24 時間):